|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | 9-(tetrahydrofuran-2-yl)-9h-purin-6-amine | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||
| 化学式 | C9H11N5O |
||||||
| 分子量 | 205.22 | CAS No. | 17318-31-9 | ||||
| Solubility (25°C)* | 体外 | DMSO | 41 mg/mL (199.78 mM) | ||||
| Water | 41 mg/mL (199.78 mM) | ||||||
| Ethanol | 41 mg/mL (199.78 mM) | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | SQ22536 (9-(tetrahydrofuran-2-yl)-9h-purin-6-amine) is an inhibitor of adenylyl cyclase with an IC50 of 1.4 μM. It can inhibit PGE1-stimulated increases in cAMP levels in intact human platelets. |
|---|---|
| in vitro | SQ22536 (250 µmol/L) attenuates the inhibitory effect of adenosine against ADP-induced platelet aggregation from 8±5 to 57±5%, respectively (p<0.001). This compound also attenuates an increase of intraplatelet levels of cAMP by adenosine from 29±2 to 9±1 pmol/108 platelets (p<0.05). It has no effect on the platelet antiaggregant activity of inosine (1 to 4 mmol/L) and ADP-induced platelet aggregation[4]. |
| in vivo | SQ22536 abolishes the renal protective effects in KK/Ta-Akita mice. the amelioration of glomerular histopathological damage is eliminated in KK/Ta-Akita mice treated with this compound. Renal cAMP does not increase after treatment with this chemical. In a word, the beneficial actions for treatment of nephropathy are inhibited by the adenylate cyclase inhibitor SQ22536[5]. |
| 細胞アッセイ | 細胞株 | Human leukemic mast cell line(HMC-1) and human umbilical cord blood-derived mast cell(hCBMCs) |
|---|---|---|
| 濃度 | 0.1, 1, 10 mM | |
| 反応時間 | 30 min | |
| 実験の流れ | HMC-1 cells and hCBMCs are plated in 48-well plates and serum-starved overnight. The next day, cells are preincubated with SQ22536 at the indicated concentrations for 30 min before stimulation with CRH (100 nM for HMC-1 or 1 μM for hCBMC) for 3 min in the presence or absence of this compound in serum-free culture media. Cell lysates are then prepared and assayed for protein kinase A activity using ELISA. |
|
| 動物実験 | 動物モデル | Male C57BL/6J mice |
| 投薬量 | 10 mg/kg | |
| 投与方法 | s.c. |
|

Data from [Data independently produced by , , ONCOLOGY REPORTS, 2017, 37:3572-3580]

Data from [Data independently produced by , , J Food Sci, 2018, 83(9):2394-2401]
| Polygonati Rhizoma Prevents Glucocorticoid-Induced Growth Inhibition of Muscle via Promoting Muscle Angiogenesis Through Deoxycholic Acid [ J Cachexia Sarcopenia Muscle, 2025, 16(3):e13853] | PubMed: 40522031 |
| Polygonati Rhizoma Prevents Glucocorticoid-Induced Growth Inhibition of Muscle via Promoting Muscle Angiogenesis Through Deoxycholic Acid [ J Cachexia Sarcopenia Muscle, 2025, 16(3):e13853] | PubMed: 40522031 |
| Wuling San regulates AVPR2-cAMP-PKA-CREB pathway to delay cellular senescence and ameliorate acute kidney injury [ J Ethnopharmacol, 2025, 347:119679] | PubMed: 40216046 |
| Intracellular Sphingosine-1-Phosphate Induces Lipolysis Through Direct Activation of Protein Kinase C Zeta [ FASEB J, 2025, 39(7):e70528] | PubMed: 40193069 |
| β-Adrenergic Blockers Increase cAMP and Stimulate Insulin Secretion Through a PKA/RYR2/TRPM5 Pathway in Pancreatic β-Cells In Vitro [ Pharmacol Res Perspect, 2025, 13(2):e70092] | PubMed: 40222952 |
| Promoting collateral formation in type 2 diabetes mellitus using ultra-small nanodots with autophagy activation and ROS scavenging [ J Nanobiotechnology, 2024, 22(1):85] | PubMed: 38429826 |
| Maternal obesity may disrupt offspring metabolism by inducing oocyte genome hyper-methylation via increased DNMTs [ Elife, 2024, 13RP97507] | PubMed: 39642055 |
| NEAT1 Deficiency Promotes Corneal Epithelial Wound Healing by Activating cAMP Signaling Pathway [ Invest Ophthalmol Vis Sci, 2024, 65(3):10] | PubMed: 38466291 |
| Suppression of cAMP/PKA/CREB signaling ameliorates retinal injury in diabetic retinopathy [ Kaohsiung J Med Sci, 2023, 10.1002/kjm2.12722] | PubMed: 37338034 |
| ACE2 pathway regulates thermogenesis and energy metabolism [ Elife, 2022, 11e72266] | PubMed: 35014608 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。